Xtant Medical Inc. (XTNT)
Xtant Medical Statistics
Share Statistics
Xtant Medical has 139.07M shares outstanding. The number of shares has increased by 6.75% in one year.
| Shares Outstanding | 139.07M |
| Shares Change (YoY) | 6.75% |
| Shares Change (QoQ) | 0.04% |
| Owned by Institutions (%) | 71.57% |
| Shares Floating | 115.26M |
| Failed to Deliver (FTD) Shares | 1.74K |
| FTD / Avg. Volume | 1.9% |
Short Selling Information
The latest short interest is 66.31K, so 0.05% of the outstanding shares have been sold short.
| Short Interest | 66.31K |
| Short % of Shares Out | 0.05% |
| Short % of Float | 0.15% |
| Short Ratio (days to cover) | 1.15 |
Valuation Ratios
The PE ratio is -3.6 and the forward PE ratio is -26.32. Xtant Medical's PEG ratio is 0.
| PE Ratio | -3.6 |
| Forward PE | -26.32 |
| PS Ratio | 0.5 |
| Forward PS | 0.5 |
| PB Ratio | 1.38 |
| P/FCF Ratio | -3.7 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Xtant Medical.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.35, with a Debt / Equity ratio of 0.3.
| Current Ratio | 2.35 |
| Quick Ratio | 1 |
| Debt / Equity | 0.3 |
| Debt / EBITDA | -1.07 |
| Debt / FCF | -0.81 |
| Interest Coverage | -2.9 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $540.4K |
| Profits Per Employee | $-75.8K |
| Employee Count | 217 |
| Asset Turnover | 1.25 |
| Inventory Turnover | 1.27 |
Taxes
| Income Tax | 187K |
| Effective Tax Rate | -1.15% |
Stock Price Statistics
The stock price has increased by -45.6% in the last 52 weeks. The beta is -0.04, so Xtant Medical's price volatility has been lower than the market average.
| Beta | -0.04 |
| 52-Week Price Change | -45.6% |
| 50-Day Moving Average | 0.47 |
| 200-Day Moving Average | 0.54 |
| Relative Strength Index (RSI) | 50.45 |
| Average Volume (20 Days) | 91.93K |
Income Statement
In the last 12 months, Xtant Medical had revenue of 117.27M and earned -16.45M in profits. Earnings per share was -0.12.
| Revenue | 117.27M |
| Gross Profit | 68.22M |
| Operating Income | -12.07M |
| Net Income | -16.45M |
| EBITDA | -12.07M |
| EBIT | -12.1M |
| Earnings Per Share (EPS) | -0.12 |
Balance Sheet
The company has 6.2M in cash and 12.94M in debt, giving a net cash position of -6.74M.
| Cash & Cash Equivalents | 6.2M |
| Total Debt | 12.94M |
| Net Cash | -6.74M |
| Retained Earnings | -259.46M |
| Total Assets | 93.84M |
| Working Capital | 38.53M |
Cash Flow
In the last 12 months, operating cash flow was -11.9M and capital expenditures -4.11M, giving a free cash flow of -16.01M.
| Operating Cash Flow | -11.9M |
| Capital Expenditures | -4.11M |
| Free Cash Flow | -16.01M |
| FCF Per Share | -0.12 |
Margins
Gross margin is 58.17%, with operating and profit margins of -10.3% and -14.03%.
| Gross Margin | 58.17% |
| Operating Margin | -10.3% |
| Pretax Margin | -13.87% |
| Profit Margin | -14.03% |
| EBITDA Margin | -10.3% |
| EBIT Margin | -10.3% |
| FCF Margin | -13.65% |
Dividends & Yields
XTNT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for XTNT is $3, which is 538.3% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3 |
| Price Target Difference | 538.3% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Feb 14, 2018. It was a backward split with a ratio of 1:12.
| Last Split Date | Feb 14, 2018 |
| Split Type | backward |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | -1.77 |
| Piotroski F-Score | 2 |